• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因组证据支持食管腺癌转移的克隆离散模型。

Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma.

机构信息

MRC Cancer Unit, University of Cambridge, Cambridge, UK.

Department of Histopathology, Papworth Hospital NHS Trust, Cambridge, UK.

出版信息

Nat Genet. 2020 Jan;52(1):74-83. doi: 10.1038/s41588-019-0551-3. Epub 2020 Jan 6.

DOI:10.1038/s41588-019-0551-3
PMID:31907488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7100916/
Abstract

The poor outcomes in esophageal adenocarcinoma (EAC) prompted us to interrogate the pattern and timing of metastatic spread. Whole-genome sequencing and phylogenetic analysis of 388 samples across 18 individuals with EAC showed, in 90% of patients, that multiple subclones from the primary tumor spread very rapidly from the primary site to form multiple metastases, including lymph nodes and distant tissues-a mode of dissemination that we term 'clonal diaspora'. Metastatic subclones at autopsy were present in tissue and blood samples from earlier time points. These findings have implications for our understanding and clinical evaluation of EAC.

摘要

食管腺癌 (EAC) 的预后不良促使我们探究转移扩散的模式和时间。对 18 名 EAC 患者的 388 个样本进行全基因组测序和系统发育分析表明,在 90%的患者中,原发肿瘤的多个亚克隆从原发部位迅速扩散,形成多个转移灶,包括淋巴结和远处组织——我们称之为“克隆离散”的播散模式。尸检时的转移亚克隆存在于更早时间点的组织和血液样本中。这些发现对我们理解和临床评估 EAC 具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/09936f4800fe/EMS84982-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/d1959b5ed31d/EMS84982-f007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/5dde3bc58cfd/EMS84982-f008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/0b031ee7515c/EMS84982-f009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/432cfa4532b5/EMS84982-f010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/c1efd76fb764/EMS84982-f011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/5b4a68bbaae9/EMS84982-f012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/98c99e3a8410/EMS84982-f013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/5ad1c033bb52/EMS84982-f014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/7d460c5ad9af/EMS84982-f015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/56d2aa34255d/EMS84982-f016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/e329219659c2/EMS84982-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/c009641f2419/EMS84982-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/63d3c1662ef9/EMS84982-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/f29fbafd96d2/EMS84982-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/fd71abad89af/EMS84982-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/09936f4800fe/EMS84982-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/d1959b5ed31d/EMS84982-f007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/5dde3bc58cfd/EMS84982-f008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/0b031ee7515c/EMS84982-f009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/432cfa4532b5/EMS84982-f010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/c1efd76fb764/EMS84982-f011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/5b4a68bbaae9/EMS84982-f012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/98c99e3a8410/EMS84982-f013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/5ad1c033bb52/EMS84982-f014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/7d460c5ad9af/EMS84982-f015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/56d2aa34255d/EMS84982-f016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/e329219659c2/EMS84982-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/c009641f2419/EMS84982-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/63d3c1662ef9/EMS84982-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/f29fbafd96d2/EMS84982-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/fd71abad89af/EMS84982-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3496/7100916/09936f4800fe/EMS84982-f006.jpg

相似文献

1
Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma.基因组证据支持食管腺癌转移的克隆离散模型。
Nat Genet. 2020 Jan;52(1):74-83. doi: 10.1038/s41588-019-0551-3. Epub 2020 Jan 6.
2
Genomic profiles of primary and metastatic esophageal adenocarcinoma identified via digital sorting of pure cell populations: results from a case report.通过对纯细胞群体的数字分选鉴定原发性和转移性食管腺癌的基因组谱:病例报告结果。
BMC Cancer. 2018 Sep 12;18(1):889. doi: 10.1186/s12885-018-4789-4.
3
Complex structural rearrangements are present in high-grade dysplastic Barrett's oesophagus samples.高级别发育异常 Barrett 食管样本中存在复杂的结构重排。
BMC Med Genomics. 2019 Feb 4;12(1):31. doi: 10.1186/s12920-019-0476-9.
4
Identification of Subtypes of Barrett's Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data.基于 DNA 甲基化谱和转录组与基因组数据整合鉴定 Barrett 食管和食管腺癌亚型。
Gastroenterology. 2020 May;158(6):1682-1697.e1. doi: 10.1053/j.gastro.2020.01.044. Epub 2020 Feb 4.
5
Integrated genomics and comprehensive validation reveal drivers of genomic evolution in esophageal adenocarcinoma.整合基因组学和综合验证揭示食管腺癌基因组进化的驱动因素。
Commun Biol. 2021 May 24;4(1):617. doi: 10.1038/s42003-021-02125-x.
6
A Model Based on Pathologic Features of Superficial Esophageal Adenocarcinoma Complements Clinical Node Staging in Determining Risk of Metastasis to Lymph Nodes.一种基于浅表性食管腺癌病理特征的模型在确定淋巴结转移风险方面补充了临床淋巴结分期。
Clin Gastroenterol Hepatol. 2016 Mar;14(3):369-377.e3. doi: 10.1016/j.cgh.2015.10.020. Epub 2015 Oct 26.
7
Whole genome expression array profiling highlights differences in mucosal defense genes in Barrett's esophagus and esophageal adenocarcinoma.全基因组表达谱分析突出了 Barrett 食管和食管腺癌黏膜防御基因的差异。
PLoS One. 2011;6(7):e22513. doi: 10.1371/journal.pone.0022513. Epub 2011 Jul 28.
8
Integrative genomics identified RFC3 as an amplified candidate oncogene in esophageal adenocarcinoma.整合基因组学鉴定 RFC3 为食管腺癌中扩增的候选癌基因。
Clin Cancer Res. 2012 Apr 1;18(7):1936-46. doi: 10.1158/1078-0432.CCR-11-1431. Epub 2012 Feb 10.
9
Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.晚期食管鳞状细胞癌和食管腺癌的综合基因组分析揭示异同
Oncologist. 2015 Oct;20(10):1132-9. doi: 10.1634/theoncologist.2015-0156. Epub 2015 Sep 2.
10
Clonal evolution of esophageal squamous cell carcinoma from normal mucosa to primary tumor and metastases.食管鳞癌从正常黏膜到原发肿瘤和转移灶的克隆进化。
Carcinogenesis. 2019 Dec 31;40(12):1445-1451. doi: 10.1093/carcin/bgz162.

引用本文的文献

1
Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of esophageal adenocarcinoma.食管腺癌新辅助治疗期间的进化与免疫微环境动态变化
Nat Cancer. 2025 May 14. doi: 10.1038/s43018-025-00955-w.
2
Gastroesophageal circulating tumor cell crosstalk with peripheral immune system guides CTC survival and proliferation.胃食管循环肿瘤细胞与外周免疫系统的相互作用指导循环肿瘤细胞的存活和增殖。
Cell Death Dis. 2025 Mar 29;16(1):223. doi: 10.1038/s41419-025-07530-2.
3
Integrating model systems and genomic insights to decipher mechanisms of cancer metastasis.

本文引用的文献

1
Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers.液体活检与组织活检在检测胃肠道癌获得性耐药及肿瘤异质性中的应用。
Nat Med. 2019 Sep;25(9):1415-1421. doi: 10.1038/s41591-019-0561-9. Epub 2019 Sep 9.
2
Quantitative evidence for early metastatic seeding in colorectal cancer.结直肠癌早期转移播种的定量证据。
Nat Genet. 2019 Jul;51(7):1113-1122. doi: 10.1038/s41588-019-0423-x. Epub 2019 Jun 17.
3
The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic.
整合模型系统与基因组学见解以破译癌症转移机制。
Nat Rev Genet. 2025 Mar 10. doi: 10.1038/s41576-025-00825-2.
4
Recurrent alterations are associated with esophageal adenocarcinoma brain metastases.复发性改变与食管腺癌脑转移相关。
medRxiv. 2025 Feb 26:2025.02.19.25322558. doi: 10.1101/2025.02.19.25322558.
5
Cancer phylogenetic inference using copy number alterations detected from DNA sequencing data.利用从DNA测序数据中检测到的拷贝数改变进行癌症系统发育推断。
Cancer Pathog Ther. 2024 Apr 18;3(1):16-29. doi: 10.1016/j.cpt.2024.04.003. eCollection 2025 Jan.
6
Context-dependent effects of CDKN2A and other 9p21 gene losses during the evolution of esophageal cancer.食管癌演变过程中CDKN2A及其他9p21基因缺失的情境依赖性效应。
Nat Cancer. 2025 Jan;6(1):158-174. doi: 10.1038/s43018-024-00876-0. Epub 2025 Jan 3.
7
Inferring cancer type-specific patterns of metastatic spread using Metient.使用Metient推断癌症类型特异性转移扩散模式。
bioRxiv. 2025 Feb 3:2024.07.09.602790. doi: 10.1101/2024.07.09.602790.
8
Decoding the interplay between genetic and non-genetic drivers of metastasis.解析转移过程中遗传和非遗传因素的相互作用。
Nature. 2024 May;629(8012):543-554. doi: 10.1038/s41586-024-07302-6. Epub 2024 May 15.
9
How much do we know about the metastatic process?我们对转移过程了解多少?
Clin Exp Metastasis. 2024 Aug;41(4):275-299. doi: 10.1007/s10585-023-10248-0. Epub 2024 Mar 23.
10
Mutational signature dynamics shaping the evolution of oesophageal adenocarcinoma.突变特征动态变化塑造食管腺癌的演进。
Nat Commun. 2023 Jul 15;14(1):4239. doi: 10.1038/s41467-023-39957-6.
551 例食管腺癌中选择的景观定义了临床基因组生物标志物。
Nat Genet. 2019 Mar;51(3):506-516. doi: 10.1038/s41588-018-0331-5. Epub 2019 Feb 4.
4
Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer.化疗耐药性肌肉浸润性膀胱癌的突变模式。
Nat Commun. 2017 Dec 19;8(1):2193. doi: 10.1038/s41467-017-02320-7.
5
Aging and neurodegeneration are associated with increased mutations in single human neurons.衰老和神经退行性变与单个人类神经元中突变增加有关。
Science. 2018 Feb 2;359(6375):555-559. doi: 10.1126/science.aao4426. Epub 2017 Dec 7.
6
Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis.突变特征揭示了在肝脏肿瘤发生过程中,风险因素和细胞过程的动态相互作用。
Nat Commun. 2017 Nov 3;8(1):1315. doi: 10.1038/s41467-017-01358-x.
7
Universal Patterns of Selection in Cancer and Somatic Tissues.癌症和体细胞组织中的普遍选择模式。
Cell. 2017 Nov 16;171(5):1029-1041.e21. doi: 10.1016/j.cell.2017.09.042. Epub 2017 Oct 19.
8
Single-cell sequencing data reveal widespread recurrence and loss of mutational hits in the life histories of tumors.单细胞测序数据揭示了肿瘤生命史中广泛的突变命中的重现和丢失。
Genome Res. 2017 Nov;27(11):1885-1894. doi: 10.1101/gr.220707.117. Epub 2017 Oct 13.
9
Three-field lymph node dissection in esophageal cancer surgery.食管癌手术中的三野淋巴结清扫术。
J Thorac Dis. 2017 Jul;9(Suppl 8):S731-S740. doi: 10.21037/jtd.2017.03.171.
10
Integrative clinical genomics of metastatic cancer.转移性癌症的整合临床基因组学
Nature. 2017 Aug 17;548(7667):297-303. doi: 10.1038/nature23306. Epub 2017 Aug 2.